A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

JH Goldie, AJ Coldman - Cancer treatment reports, 1979 - europepmc.org
A mathematic model has been developed relating the drug sensitivity of a tumor to its own
spontaneous mutation rate towards phenotypic drug resistance. The proportion as well as the …

[HTML][HTML] Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

…, CML Coppin, M Paradis, AJ Coldman… - … England Journal of …, 1997 - Mass Medical Soc
Background Radiotherapy after mastectomy to treat early breast cancer has been known
since the 1940s to reduce rates of local relapse. However, the routine use of postoperative …

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

…, K Gelmon, N Le, R Durand, AJ Coldman… - Journal of the …, 2005 - academic.oup.com
Background: The British Columbia randomized radiation trial was designed to determine
the survival impact of locoregional radiation therapy in premenopausal patients with lymph …

Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer: I. Basal cell carcinoma

…, CD Bajdik, S Fincham, AJ Coldman… - Archives of …, 1995 - jamanetwork.com
Background and Design: Basal cell carcinoma (BCC) of the skin is the most common
neoplasm in white populations, and solar radiation is generally accepted to be the dominant …

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

…, PM Ravdin, CH Speers, AJ Coldman… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Adjuvant! ( www.adjuvantonline.com ) is a web-based tool that predicts 10-year
breast cancer outcomes with and without adjuvant systemic therapy, but it has not been …

The genetic origin of drug resistance in neoplasms: implications for systemic therapy

JH Goldie, AJ Coldman - Cancer research, 1984 - AACR
Coldman, AJ, and Goldie, JH A model for the resistance of lumor cells to cancer … Goldie,
JH, and Coldman, AJ Quantitative model for multiple levels of drug resistance in clinical tumors. …

[HTML][HTML] Rationale for the Use of Alternating Non-Cross-Resistant Chemotherapy¹

JH Goldie, AJ Coldman… - Cancer treatment reports, 1982 - books.google.com
In this paper an argument is presented for examining the rationale for the use of alternating
non-cross-resistant chemotherapy. It is assumed that the development of a doubly resistant …

Assessment of adult cancer pain: shortcomings of current methods

M Deschamps, PR Band, AJ Coldman - Pain, 1988 - journals.lww.com
: The evaluation of cancer pain remains a problematic clinical problem, not only due to the
subjective and multidimensional nature of pain per se, but also because of its specific …

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

…, SE O'Reilly, P Hoskins, AJ Coldman… - Blood, The Journal …, 1997 - ashpublications.org
The prognostic significance of Bcl-2 protein expression and bcl-2 gene rearrangement in
diffuse large cell lymphomas (DLCL) is controversial. Bcl-2 protein expression prevents …

Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer: II. Squamous cell carcinoma

…, GB Hill, CD Bajdik, AJ Coldman… - Archives of …, 1995 - jamanetwork.com
Introduction and Design: Squamous cell carcinoma of the skin (SCC), a common cancer in
white populations, is related to sunshine exposure; however, relatively little information is …